Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | -1.00% | -4.81% | -83.06% |
09/05 | EFFECTOR Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04/04 | Health Care Down on Retreat From Risk -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.06% | 94.09L | |
+6.94% | 11TCr | |
+10.76% | 11TCr | |
-12.69% | 2.22TCr | |
+0.44% | 2.13TCr | |
-4.18% | 1.9TCr | |
-37.85% | 1.85TCr | |
-10.02% | 1.68TCr | |
+38.77% | 1.25TCr | |
-24.55% | 808.97Cr |
- Stock Market
- Equities
- EFTR Stock
- News eFFECTOR Therapeutics, Inc.
- Credit Suisse Lowers eFFECTOR Therapeutics' Price Target to $14 from $16, Keeps Outperform Rating